The growth hormone-releasing peptide KP-102 activates neurons in the arcuate nucleus (a key GH-regulating brain area), and this effect persists even without the pituitary gland.
Direct brain action confirmedKP-102 activated arcuate nucleus neurons even in rats without pituitary glands, proving GHRPs act directly on the hypothalamus
What the researchers found
KP-102 induces c-fos expression specifically in the arcuate nucleus, and this occurs even in hypophysectomized rats, confirming a direct hypothalamic site of action.
Why it matters
Proving GHRPs act directly on the hypothalamus (not just the pituitary) revealed a dual mechanism of action, explaining their potent GH-releasing effects and supporting combination therapy with GHRH.
How the study worked
Rat brains were processed for in situ hybridization of c-fos mRNA after systemic KP-102 administration. Both intact and hypophysectomized (pituitary-removed) adult male Wistar rats were tested.
What this study cannot tell us
Animal study with a specific GHRP variant (KP-102). The c-fos marker shows activation but doesn't reveal the functional consequence. Hypophysectomy creates an artificial state.
How to read the evidence
Moderate animal evidence using a well-validated neuronal activity marker. Hypophysectomy experiment provides strong mechanistic proof.
When this study was published
Published in 1996, this study helped establish the hypothalamic mechanism of GHRPs before the ghrelin receptor was fully characterized.
The bigger picture
The arcuate nucleus finding helped explain why GHRPs and GHRH have synergistic effects — they work at different levels (hypothalamus vs. pituitary), supporting clinical combination protocols.
Questions still open
- Do all GHRPs activate the same hypothalamic neurons?
- Could targeting arcuate nucleus activation optimize GHRP-based GH therapies?
Common questions
What is the arcuate nucleus?
Why does it matter that GHRPs work on the brain?
Read the original research
The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus.
Brain research. Molecular brain research, 39(1-2), 153-9
Citation
Kamegai, J; Hasegawa, O; Minami, S; Sugihara, H; Wakabayashi, I. (1996). The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus.. Brain research. Molecular brain research, 39(1-2), 153-9.